학술논문

Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXIV. Cytotoxic treatment is an additional risk factor for the development of symptomatic osteonecrosis in lupus patients: results of a nested matched case-control study.
Document Type
journal article
Source
Annals of the Rheumatic Diseases; Jun2006, p785-790, 6p
Subject
THERAPEUTIC use of glucocorticoids
ANTINEOPLASTIC antibiotics
RESEARCH
OSTEONECROSIS
COMBINATION drug therapy
HISPANIC Americans
BLACK people
RESEARCH methodology
EVALUATION research
MEDICAL cooperation
DRUG administration
COMPARATIVE studies
RESEARCH funding
ETHNIC groups
SYSTEMIC lupus erythematosus
HYDROXYCHLOROQUINE
WHITE people
EPIDEMIOLOGICAL research
DISEASE complications
Language
ISSN
00034967
Abstract
Copyright of Annals of the Rheumatic Diseases is the property of BMJ Publishing Group and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)